Considerations on SARS-Cov-2 vaccines in patients with autoimmune blistering diseases. Cozzani E, Gasparini G, Sticchi L, Russo R, et al. Eur J Dermatol 2021;31:415-417.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cozzani E, Gasparini G, Sticchi L, Russo R, et al. Considerations on SARS-Cov-2 vaccines in patients with autoimmune blistering diseases. Eur J Dermatol 2021;31:415-417.
PMID: 34309530